Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
It seems we are on the right track and more focused instead of being all over.
Quelle est la meilleure partie de votre programme de rémunération?
Health Care insurance & Vision Plan
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Some of the individuals in the LT are still in toxic mode.
Quelles sont les meilleures choses à propos de votre équipe?
The team is willing to turn on the page and start with a fresh mindset; however, the SVP still has the old attitude. He does not motivate or inspire employees.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
I like the new culture and the new LT members. They are sharp and have been in the industry for years. They will make a positive change to the company.
Qu’est-ce qui vous rend le plus heureux au travail?
It makes me happy knowing that we can help patients in need. The KEAP program is a great example of what the company offers for people who cannot afford to pay for the drug.
Other Employee Reviews for Karyopharm Therapeutics
×